Family Medicine · South Bend, IN
NPI
1225031925
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2102 E Inwood Rd
South Bend, IN, 46614
Phone (574) 299-2400
Groups this clinician bills Medicare through
Medicare paid, 2024
$116K
5,027 services
Medicare patients, 2024
227
Average age 75
Drug cost, 2024
$715K
7,270 prescriptions
Company payments, 2025
$1,636
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert D Lee was code 99214 (office e&m - established), 604 times for 201 patients. In total Robert D Lee billed 5,027 services in 77 codes, and Medicare paid $116K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 604 | 201 | $75.16 | $45K |
| 36415 Venipuncture Blood Collection | Office | 317 | 169 | $8.65 | $2,742 |
| 85025 Blood Count | Office | 202 | 147 | $7.61 | $1,537 |
| 80053 Clinical Chemistry | Office | 200 | 153 | $10.35 | $2,070 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 139 | 139 | $114.15 | $16K |
| 80061 Clinical Chemistry | Office | 109 | 103 | $13.12 | $1,430 |
| 83036 Blood Count | Office | 106 | 62 | $9.52 | $1,009 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 84 | 12 | $41.87 | $3,517 |
| 83735 Clinical Chemistry | Office | 82 | 59 | $6.57 | $539 |
| 81001 Clinical Chemistry | Office | 70 | 64 | $3.11 | $218 |
| 99213 Office E&M - Established | Office | 66 | 52 | $58.88 | $3,886 |
| 84443 Clinical Chemistry | Office | 43 | 38 | $16.46 | $708 |
| 82570 Clinical Chemistry | Office | 35 | 35 | $5.08 | $178 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 32 | 25 | $202.67 | $6,486 |
| 80048 Clinical Chemistry | Office | 31 | 27 | $8.29 | $257 |
By year: 2022 $86K for 2,173 services; 2023 $106K for 4,511 services; 2024 $116K for 5,027 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 317 | 169 | $8.65 | $2,742 |
| 85025 Blood Count | 202 | 147 | $7.61 | $1,537 |
| 80053 Clinical Chemistry | 200 | 153 | $10.35 | $2,070 |
| 80061 Clinical Chemistry | 109 | 103 | $13.12 | $1,430 |
| 83036 Blood Count | 106 | 62 | $9.52 | $1,009 |
| 83735 Clinical Chemistry | 82 | 59 | $6.57 | $539 |
| 81001 Clinical Chemistry | 70 | 64 | $3.11 | $218 |
| 84443 Clinical Chemistry | 43 | 38 | $16.46 | $708 |
| 82570 Clinical Chemistry | 35 | 35 | $5.08 | $178 |
| 80048 Clinical Chemistry | 31 | 27 | $8.29 | $257 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert D Lee prescribed most often to Medicare patients was Atorvastatin Calcium, with 566 prescriptions and refills. In total Robert D Lee wrote 7,270 Medicare prescriptions that cost $715K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 566 | 1,629 | 169 | $3,831 |
| Amlodipine Besylate Generic | 355 | 1,018 | 104 | $1,818 |
| Levothyroxine Sodium Generic | 271 | 740 | 79 | $2,168 |
| Losartan Potassium Generic | 249 | 683 | 75 | $1,515 |
| Lisinopril Generic | 207 | 586 | 62 | $832 |
| Metformin Hcl Generic | 202 | 574 | 61 | $1,249 |
| Hydrochlorothiazide Generic | 179 | 525 | 50 | $816 |
| Tamsulosin Hcl Generic | 177 | 483 | 52 | $2,315 |
| Omeprazole Generic | 174 | 474 | 47 | $2,537 |
| Pantoprazole Sodium Generic | 167 | 445 | 58 | $1,579 |
| Jardiance Empagliflozin | 149 | 303 | 40 | $178K |
| Gabapentin Generic | 143 | 329 | 42 | $2,309 |
| Simvastatin Generic | 141 | 416 | 41 | $1,062 |
| Alprazolam Generic | 136 | 155 | 31 | $525 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 131 | 131 | 20 | $3,109 |
Brand drugs: 858 claims; generic drugs: 6,374 claims; opioid claims: 288.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert D Lee $1,636 ($1,636 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $288.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 10 | $288 |
| Abbvie Inc. ABBV | 18 | $287 |
| Lilly USA, LLC LLY | 10 | $261 |
| Pfizer Inc. PFE | 9 | $246 |
| Novo Nordisk Inc NVO | 6 | $113 |
| Amgen Inc. AMGN | 6 | $91.67 |
| Exact Sciences Corporation EXAS | 4 | $65.32 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $64.88 |
| Abbott Laboratories ABT | 2 | $47.09 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.